Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

126.06 -3.13 (-2.43%)
Streaming Delayed Price Updated: 10:34 AM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about TransMedics Group, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
TRANSMEDICS GROUP INC (NASDAQ:TMDX) – A High-Growth Momentum Stock with Strong Technical Setup
TRANSMEDICS (TMDX) shows strong earnings momentum with 500% EPS growth and a solid technical setup, making it a candidate for high-growth investors. 
Via Chartmill
Is TransMedics Stock a Buy After Short-Seller Drama?
Via The Motley Fool
2 Stocks That Have Doubled This Year and Are Still Worth Buying
Via The Motley Fool
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
Via The Motley Fool
Topics Artificial Intelligence
Price Over Earnings Overview: TransMedics Group
Via Benzinga
4 Analysts Have This To Say About TransMedics Group
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
P/E Ratio Insights for TransMedics Group
Via Benzinga
Down 62%. Should You Buy TransMedics Stock on the Dip?
Via The Motley Fool
Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May
TransMedics Group and two other mid-cap names just posted dominant performances in Q1, smashing forecasts set by Wall Street analysts. 
Via MarketBeat
Topics Earnings
3 Medical Technology Stocks Outperforming in 2025
Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns. 
Via MarketBeat
3 High-Growth Stocks Traders Love and Investors Should Watch
These three small stocks carry significant risk, but that volatility has served traders well this year; now it's time for long-term investors to take a look 
Via MarketBeat
Topics Economy
TRANSMEDICS GROUP INC (NASDAQ:TMDX) – A High-Growth Momentum Stock with Strong Technical Setup
TRANSMEDICS (TMDX) shows strong earnings growth and improving margins while presenting a favorable technical setup, making it interesting for momentum investors. 
Via Chartmill
Is the Market Bullish or Bearish on TransMedics Gr?
Via Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
2 Brilliant Stocks to Buy With $200 and Hold for 5 Years
Via The Motley Fool
TransMedics Group Stock Is Up 81% in 2025. Can It Climb Even Higher?
Via The Motley Fool
Why TransMedics Stock Is Skyrocketing Today
Via The Motley Fool
Insulet Posts Upbeat Earnings, Joins Trade Desk, TransMedics Group, Tesla And Other Big Stocks Moving Higher On Friday
Via Benzinga
Former Highflier TransMedics Catapults To Seven-Month High On Liver-Driven Beat
The company is an expert in getting donated livers, hearts and lungs to transplant recipients. 
Via Investor's Business Daily
Topics Government
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Thursday?
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
3 Mid-Cap Medical Stocks Outperforming the Market
Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness. 
Via MarketBeat
Topics Economy
1 Beaten-Down Stock to Buy Right Now and Hold for a Decade
Via The Motley Fool
Topics Government World Trade
Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock
Via Benzinga
TransMedics Group Stock: A Millionaire-Maker in the Making?
Via The Motley Fool
1 Compelling Reason to Buy and Hold TransMedics Group Stock Forever
Via The Motley Fool
1 Turnaround Growth Stock Down 60% That Could Double, According to Wall Street
Via The Motley Fool
TransMedics' Revenue Surged 49.8% in Q4
The organ transplant technology specialist significantly exceeded Wall Street's estimates in the fourth quarter. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.